Özlem ŞENGÜL, Dilek UYGUR, Mustafa GÜLEÇ, Berna DİLBAZ, Esma Meltem ŞİMŞEK, Ümit GÖKTOLGA

The comparison of folate and vitamin B12 levels between depressive and nondepressive postmenopausal women

To investigate if there is any association between the serum folate and vitamin B12 status and the depressive symptoms in postmenopausal women. Materials and methods: The study included 95 postmenopausal women. The Center for Epidemiologic Studies Depression Scale (CES-D) was used to assess their depressive symptoms. The investigated women were classified into 2 groups based on the existence of depressive symptoms. These 2 groups were compared in terms of folic acid and vitamin B12 levels. Results: Among 95 cases, 27 postmenopausal women scored 16 or more on the CES-D scale and were classified as the depressive group (Group 1), and 68 postmenopausal women scored 15 or less and were classified as the nondepressive group (Group 2). The serum levels of folate were 11.5 ± 5.4 ng/mL in group 1 and 12.3 ± 5.3 ng/mL in group 2. The concentrations of vitamin B12 were 456.2 ± 343.4 pg/mL in group 1 and 446.5 ± 165.1 pg/mL in group 2. The folate and vitamin B12 levels did not significantly correlate to the frequency of depressive symptoms (P = 0.52 and P = 0.24, respectively). Conclusion: In this study, no correlation was detected between serum folate and vitamin B12 levels and depressive symptoms in postmenopausal women. Supplementation of folic acid and vitamin B12 for postmenopausal women does not seem to be an effective intervention to reduce depressive symptoms.

Anahtar Kelimeler:

Key words: Depressive symptoms, folate, menopause, vitamin B12

The comparison of folate and vitamin B12 levels between depressive and nondepressive postmenopausal women

Keywords:

Key words: Depressive symptoms, folate, menopause, vitamin B12,

PDF

___

Gracia CR, Freeman EW, Sammel MD, Lin H, Mogul M. Hormones and sexuality during transition to menopause. Obstet Gynecol 2007; 109: 831–840.
Leung BM, Kaplan BJ. Perinatal depression prevalence, risks, and the nutrition link—a review of the literature. J Am Diet Assoc 2009; 109: 1566–1575.
Herrmann W, Obeid R. Biomarkers of folate and vitamin B(12) status in cerebrospinal fluid. Clin Chem Lab Med 2007; 45: 1614–1620.
Słopiena R, Jasniewicz K, Meczekalski B, WarenikSzymankiewicz A, Lianeri M, Jagodzinski PP. Polymorphic variants of genes encoding MTHFR, MTR, and MTHFD1 and the risk of depression in postmenopausal women in Poland. Maturitas 2008; 61: 252–255.
Fava M, Mischoulon D. Evidence for folate in combination with antidepressants at initiation of therapy. J Clin Psychiatry 2010; 71: e
Miller AL. The methylation, neurotransmitter, and antioxidant connections between folate and depression. Altern Med Rev 2008; 13: 216–226.
Clarke R, Smith AD, Jobst KA, Refsum H, Sutton L, Ueland PM. Folate, vitamin B12, and serum total homocysteine levels in confirmed Alzheimer disease. Arch Neurol 1998; 55: 1449–1455.
Tiemeier H, van Tuijl HR, Hofman A, Meijer J, Kiliaan AJ, Breteler MM. Vitamin B12, folate, and homocysteine in depression: The Rotterdam Study. Am J Psychiatry 2002; 159: 2099–2101.
Nanri A. Nutritional epidemiology of type 2 diabetes and depressive symptoms. J Epidemiol 2013; 23: 243–250.
Radloff LS. The CES-D scale: A self-report depression scale for research in the general population. Appl Psychol Meas 1997; 1: 385–401.
Freeman EW. Associations of depression with the transition to menopause. Menopause 2010; 17: 823–827.
Bromberger JT, Matthews KA, Schott LL, Brockwell S, Avis NE, Kravitz HM, Everson-Rose SA, Gold EB, Sowers M, Randolph JF Jr. Depressive symptoms during the menopausal transition: The Study of Women’s Health Across the Nation (SWAN). J Affect Disord 2007; 103: 267–272.
Beydoun MA, Kuczmarski MT, Beydoun HA, Shroff MR, Mason MA, Evans MK, Zonderman AB. The sex-specific role of plasma folate in mediating the association of dietary quality with depression symptoms. J Nutr 2009; 140: 338–348.
Bottiglieri T. Homocysteine and folate metabolism in depression. Prog Neuropsychopharmacol Biol Psychiatry 2005; 29: 1103– 1
D’Anci KE, Rosenberg IH. Folate and brain function in the elderly. Curr Opin Clin Nutr Metab Care. 2004; 7: 659–664.
Bottiglieri T, Laundy M, Crellin R, Toone BK, Carney MW, Reynolds EH. Homocysteine, folate, methylation, and monoamine metabolism in depression. J Neurol Neurosurg Psychiatry 2000; 69: 228–232.
Bell IR, Edman JS, Morrow FD, Marby DW, Mirages S, Perrone G, Kayne HL, Cole JO. B complex vitamin patterns in geriatric and young adult in patients with major depression. J Am Geriatr Soc 1991; 39: 252–257.
Almeida OP, Marsh K, Alfonso H, Flicker L, Davis TM, Hankey GJ. B- vitamins reduce the long-term risk of depression after stroke: the VITATORS-DEP trial. Ann Neurol 2010; 68: 503– 5
Brocardo PS, Budni J, Kaster MP, Santos AR, Rodrigues AL. Folic acid administration produces an antidepressant-like effect in mice: evidence for the involvement of the serotonergic and noradrenergic systems. Neuropharmacology 2008; 54: 464–473.
Lazarou C, Kapsou M. The role of folic acid in prevention and treatment of depression: an overview of existing evidence and implications for practice. Complement Ther Clin Pract 2010; 16: 161–166.
Nanri A, Mizoue T, Matsushita Y, Sasaki S, Ohta M, Sato M, Mishima N. Serum folate and homocysteine and depressive symptoms among Japanese men and women. Eur J Clin Nutr 2010; 64: 289–296.
Walker JG, Mackinnon AJ, Batterham P, Jorm AF, Hickie I, McCarthy A, Fenech M, Christensen H. Mental health literacy, folic acid and vitamin B 12, and physical activity for the prevention of depression in older adults: randomised controlled trial. Br J Psychiatry 2010; 197: 45–54.
Watanabe H, Suganuma N, Hayashi A, Hirowatari Y, Hirowatari, Ohsawa M. No relation between folate and homocysteine levels and depression in early pregnant women. Bio Science Trends 2010; 4: 344–350.
Miyake Y, Sasaki S, Tanaka K, Yokoyama T, Ohya Y, Fukushima W, Saito K, Ohfuji S, Kiyohara C, Hirota Y et al. Dietary folate and vitamins B12, B6, and B2 intake and the risk of postpartum depression in Japan: The Osaka Maternal and Child Health Study. J Affect Disord 2006; 96: 133–138.
Penninx BW, Guralnik JM, Ferrucci L, Fried LP, Allen RH, Stabler SP. Vitamin B12 deficiency and depression in physically disabled older women: epidemiologic evidence from the Women’s Health and Aging Study. Am J Psychiatry 2000; 157: 715–721.
Freeman EW, Sammel MD, Liu L, Gracia CR, Nelson DB, Hollander L. Hormones and menopausal status as predictors of depression in women in transition to menopause. Arch Gen Psychiatry 2004; 61: 62–70.
Canbal M, Şencan İ, Şahin A, Kunt Ş, Çavuş UY, Tekin O. Effects of depression and life factors on social network score in elderly people in Çankaya, Ankara. Turk J Med Sci 2012; 42: 725–731.
Bonari L, Pinto N, Ahn E, Einarson A, Steiner M, Koren G. Perinatal risks of untreated depression during pregnancy. Can J Psychiatry 2004; 49: 726–735.
Kitamura T, Shima S, Sugawara M, Toda MA. Clinical and psychosocial correlates of antenatal depression: a review. Psychother Psychosom 1996; 65: 117–123.
Lambie DG, Johnson RH. Drugs and folate metabolism. Drugs 1985; 30: 145–155.
Baltacı D, Kutlucan A, Öztürk S, Karabulut İ, Yıldırım HA, Çeler A, Celbek G, Kara İH. Evaluation of vitamin B-12 level in middle-aged obese women with metabolic and non-metabolic syndrome: case-control study. Turk J Med Sci 2012; 42: 802–809.